Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
2020 ◽
Vol 21
(9)
◽
pp. 1188-1200
◽
2016 ◽
Vol 17
(7)
◽
pp. 928-942
◽
Keyword(s):
2015 ◽
Vol 16
(13)
◽
pp. 1370-1379
◽
2020 ◽
Vol 190
(5)
◽
pp. 736-740
◽
Keyword(s):